Artificial intelligence designed drugs Hit 90% Phase I success rate in trials
1. AI-native biotechnology firms are reporting Phase I success rates between 80% and 90%, nearly doubling the historical industry average ...
1. AI-native biotechnology firms are reporting Phase I success rates between 80% and 90%, nearly doubling the historical industry average ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.